Thromb Haemost 2001; 86(06): 1593-1594
DOI: 10.1055/s-0037-1616776
Letters to the Editor
Schattauer GmbH

A Family History of Type 2 Diabetes Is Associated with Lower Sensitivity to Activated Protein C in Overweight and Obese Premenopausal Women

N. Pannacciulli
1   Internal Medicine, Endocrinology, and Metabolic Diseases, Department of Emergency and Transplants
,
V. De Mitrio
1   Internal Medicine, Endocrinology, and Metabolic Diseases, Department of Emergency and Transplants
,
M. Sciaraffia
1   Internal Medicine, Endocrinology, and Metabolic Diseases, Department of Emergency and Transplants
,
R. Giorgino
1   Internal Medicine, Endocrinology, and Metabolic Diseases, Department of Emergency and Transplants
,
G. De Pergola
1   Internal Medicine, Endocrinology, and Metabolic Diseases, Department of Emergency and Transplants
› Author Affiliations
Further Information

Publication History

Received 13 February 2001

Accepted after resubmission 12 September 2001

Publication Date:
12 December 2017 (online)

 

 
  • References

  • 1 Pierce M, Keen H, Bradley C. Risk of diabetic in offspring of parents with non-insulin-dependent diabetes. Diabetic Medicine 1995; 12: 6-13.
  • 2 Makris TK, Krespi PG, Hatzizacharias AN, Gialeraki AE, Anastasiadis G, Triposkiadis FK, Mandalaki T, Kyriakidis MK. Resistance to activated protein C and FV Leiden mutation in patients with a history of acute myocardial infarction or primary hypertension. Am J Hypertens 2000; 13 1 pt 1 61-5.
  • 3 Ripoll L, Mazoyer E, Baudin B, Lacam S, Varsat L, Drouet O. Can high plasma ceruloplasmin levels cause acquired activated protein C resistance?. Thromb Haemost 1998; 79: 449-50.
  • 4 Cignarelli M, De Pergola G, Picca G, Sciaraffia M, Pannacciulli N, Tarallo M, Laudadio E, Turrisi V, Giorgino R. Relationship of obesity and body fat distribution with ceruloplasmin serum levels. Int J Obesity 1996; 20: 809-13.
  • 5 De Mitrio V, Marino R, Cicinelli E, Galantino P, Di Bari F, Giannoccaro F, De Pergola G, Lapecorella M, Schonauer S, Schiraldi O. Beneficial effects of postmenopausal hormone replacement therapy with transdermal estradiol on sensitivity to activated protein C. Blood, Coagulation and Fibrinolysis 2000; 11: 175-82.